This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Odds, F C Search for Related Content PubMed PubMed Citation Articles by Odds, F C

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1982 November; 22(5): 763-770

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

F C Odds

ABSTRACT

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and micoconazole were tested for all possible paired and triple drug combinations and all four drugs combined against three isolates of Candida albicans, three Candida spp., two isolates of Cryptococcus neoformans, and three isolates Aspergillus fumigatus. An assay for inhibitory activity was developed in which growth in the presence of an antifungal agent was expressed as a percentage of the growth in drug-free cultures. For nearly all of the antifungal combinations, the interaction was additive against most fungal isolates. Drug combinations that included amphotericin B and ketoconazole were most often synergistic, i.e., amphotericin plus ketoconazole, amphotericin plus 5-fluorocytosine plus ketoconazole, and amphotericin plus 5-fluorocytosine plus ketoconazole plus miconazole, whereas the combination of ketoconazole plus miconazole showed the strongest tendency towards antagonism. The data in this screening survey provide a basis for further studies of drug interactions in vivo and in vitro.

---

Antimicrob Agents Chemother. 1982 November; 22(5): 763-770

This article has been cited by other articles:

• Lignell, A., Lowdin, E., Cars, O., Sjolin, J. (2008). Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model. J Antimicrob Chemother 62: 142-148 [Abstract] [Full Text]  
• O'Shaughnessy, E. M., Meletiadis, J., Stergiopoulou, T., P. Demchok, J., Walsh, T. J. (2006). Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species. J Antimicrob Chemother 58: 1168-1176 [Abstract] [Full Text]  
• Singh, N., Paterson, D. L. (2005). Aspergillus Infections in Transplant Recipients. Clin. Microbiol. Rev. 18: 44-69 [Abstract] [Full Text]  
• Cuenca-Estrella, M. (2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother 54: 854-869 [Abstract] [Full Text]  
• Te Dorsthorst, D. T. A., Verweij, P. E., Meis, J. F. G. M., Punt, N. C., Mouton, J. W. (2004). In Vitro Interactions between Amphotericin B, Itraconazole, and Flucytosine against 21 Clinical Aspergillus Isolates Determined by Two Drug Interaction Models. Antimicrob. Agents Chemother. 48: 2007-2013 [Abstract] [Full Text]  
• Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H. (2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother. 48: 693-715 [Full Text]  
• Schwarz, P., Dromer, F., Lortholary, O., Dannaoui, E. (2003). In Vitro Interaction of Flucytosine with Conventional and New Antifungals against Cryptococcus neoformans Clinical Isolates. Antimicrob. Agents Chemother. 47: 3361-3364 [Abstract] [Full Text]  
• Pacetti, S. A, Gelone, S. P (2003). Caspofungin Acetate for Treatment of Invasive Fungal Infections. The Annals of Pharmacotherapy 37: 90-98 [Abstract] [Full Text]  
• Liao, R. S., Rennie, R. P., Talbot, J. A. (1999). Assessment of the Effect of Amphotericin B on the Vitality of Candida albicans. Antimicrob. Agents Chemother. 43: 1034-1041 [Abstract] [Full Text]